IL18 and Parkinson disease: Together, these factors lead to exacerbation of the inflammatory response present in PD, further accumulation of α-synuclein aggregates [16], and the release of caspase-1, ASC, and IL-18 that can be detected in the blood of patients with PD (Figure 3).